Case Report: New insights about clinical manifestations of patients with GCK genetic variants
GCK-MODY is a genetic condition characterized by alterations in the <i>GCK</i> gene, which can include several types of inactivating genetic variants - ranging from missense and nonsense variants, and splice site variants, to small and large deletions and insertions in the gene. This disorder primarily affects glucose homeostasis and usually presents in heterozygous individuals. Although GCK-MODY is a well-studied condition, some variant carriers may manifest symptoms that deviate from the typical disease phenotype. Our study identified two Brazilian patients with GCK-MODY carrying novel frameshift variants, one of whom presented atypical manifestations of the disease. The patient is a 14-year-old male harboring a variant c.398del; p.(Phe133SerfsTer7) in the <i>GCK</i> gene. He presented with the typical clinical features of GCK-MODY, including mild and stable fasting hyperglycemia, however, he also presented a history of polyuria and polydipsia, which are unusual symptoms of the disease. These symptoms could be associated with the more severe impact of a frameshift variant. However, we did not observe the same unusual phenotype in our second patient, who is a 15-year-old normal-weight female. At the age of 8, she was diagnosed with diabetes mellitus. The patient with the p.(Val335ArgfsTer124) variant presented with mild, stable hyperglycemia, a characteristic feature of the disease. In this study, we present two cases of novel frameshift variants in <i>GCK</i> and review other reports in the literature that have shown patients with atypical manifestations of the disease and highlight the importance of a comprehensive characterization of the phenotypic spectrum caused by GCK-MODY variants.
Authors
- Roberta Magalhães Tarantino (ORCID: https://orcid.org/0000-0001-7759-1564)
- Maria Chiara Di Bernardo
- Pedro Hernán Cabello (ORCID: https://orcid.org/0000-0002-1389-5064)
- Kaio Cezar Rodrigues Salum (ORCID: https://orcid.org/0000-0002-7079-6601)
- Ritiele Bastos de Souza (ORCID: https://orcid.org/0000-0002-6996-3388)
- Verônica Marques Zembrzuski (ORCID: https://orcid.org/0000-0002-0044-3210)
- Melanie Rodacki (ORCID: https://orcid.org/0000-0002-9007-1325)
- Jorge Luiz Luescher (ORCID: https://orcid.org/0000-0003-4272-6160)
- A Andrade
- Lenita Zajdenverg (ORCID: https://orcid.org/0000-0002-1579-3299)
- Mário Campos (ORCID: https://orcid.org/0000-0002-7121-0748)
- Gabriella de Medeiros Abreu (ORCID: https://orcid.org/0000-0002-0434-3815)
- Ana Carolina Proença da Fonseca (ORCID: https://orcid.org/0000-0001-6123-0481)
- Renata Szundy Berardo
- Deborah Snaider Nicolay
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade Unigranrio (BR)
- Hospital Federal dos Servidores do Estado (BR)
- Hospital Universitário Clementino Fraga Filho (BR)
- Fundação Oswaldo Cruz (BR)
- Universidade Federal do Estado do Rio de Janeiro (BR)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.3389/fendo.2025.1549279
- Primary Topic
- Glycosylation and Glycoproteins Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro